Research Paper
Long‐term follow‐up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13‐cis‐retinoic acid and dihydroxylated vitamin D3: independent positive impact of erythroid response on survival